BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30336783)

  • 21. Daxx cooperates with the Axin/HIPK2/p53 complex to induce cell death.
    Li Q; Wang X; Wu X; Rui Y; Liu W; Wang J; Wang X; Liou YC; Ye Z; Lin SC
    Cancer Res; 2007 Jan; 67(1):66-74. PubMed ID: 17210684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.
    Lin DY; Huang YS; Jeng JC; Kuo HY; Chang CC; Chao TT; Ho CC; Chen YC; Lin TP; Fang HI; Hung CC; Suen CS; Hwang MJ; Chang KS; Maul GG; Shih HM
    Mol Cell; 2006 Nov; 24(3):341-54. PubMed ID: 17081986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
    Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
    Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated Peritonitis.
    Yoshida M; Taguchi A; Kawana K; Adachi K; Kawata A; Ogishima J; Nakamura H; Fujimoto A; Sato M; Inoue T; Nishida H; Furuya H; Tomio K; Arimoto T; Koga K; Wada-Hiraike O; Oda K; Nagamatsu T; Kiyono T; Osuga Y; Fujii T
    PLoS One; 2016; 11(8):e0160330. PubMed ID: 27483433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daxx: death or survival protein?
    Salomoni P; Khelifi AF
    Trends Cell Biol; 2006 Feb; 16(2):97-104. PubMed ID: 16406523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death.
    Junn E; Taniguchi H; Jeong BS; Zhao X; Ichijo H; Mouradian MM
    Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9691-6. PubMed ID: 15983381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML.
    Lehembre F; Müller S; Pandolfi PP; Dejean A
    Oncogene; 2001 Jan; 20(1):1-9. PubMed ID: 11244500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daxx is a key downstream component of receptor interacting protein kinase 3 mediating retinal ischemic cell death.
    Lee YS; Dayma Y; Park MY; Kim KI; Yoo SE; Kim E
    FEBS Lett; 2013 Jan; 587(3):266-71. PubMed ID: 23260419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms.
    Matte I; Lane D; Laplante C; Garde-Granger P; Rancourt C; Piché A
    Int J Cancer; 2015 Jul; 137(2):289-98. PubMed ID: 25482018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of c-met expression by transcription repressor Daxx.
    Morozov VM; Massoll NA; Vladimirova OV; Maul GG; Ishov AM
    Oncogene; 2008 Apr; 27(15):2177-86. PubMed ID: 17952115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The death domain-associated protein modulates activity of the transcription co-factor Skip/NcoA62.
    Tang J; Chang HY; Yang X
    FEBS Lett; 2005 May; 579(13):2883-90. PubMed ID: 15878163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
    Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
    Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daxx inhibits stress-induced apoptosis in cardiac myocytes.
    Zobalova R; Swettenham E; Chladova J; Dong LF; Neuzil J
    Redox Rep; 2008; 13(6):263-70. PubMed ID: 19017466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Progress on the subcellular localization of Daxx].
    Chen SF; Zhu CM; Wan YP
    Ai Zheng; 2009 Dec; 28(12):1333-6. PubMed ID: 19958631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice.
    Pourgholami MH; Yan Cai Z; Lu Y; Wang L; Morris DL
    Clin Cancer Res; 2006 Mar; 12(6):1928-35. PubMed ID: 16551879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visfatin derived from ascites promotes ovarian cancer cell migration through Rho/ROCK signaling-mediated actin polymerization.
    Li Y; Li X; Liu KR; Zhang JN; Liu Y; Zhu Y
    Eur J Cancer Prev; 2015 May; 24(3):231-9. PubMed ID: 25055182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical role for Daxx in regulating Mdm2.
    Tang J; Qu LK; Zhang J; Wang W; Michaelson JS; Degenhardt YY; El-Deiry WS; Yang X
    Nat Cell Biol; 2006 Aug; 8(8):855-62. PubMed ID: 16845383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer.
    Li J; Huang H; Li Y; Li L; Hou W; You Z
    Oncol Rep; 2016 Dec; 36(6):3241-3250. PubMed ID: 27779700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Berbamine suppresses cell proliferation and promotes apoptosis in ovarian cancer partially via the inhibition of Wnt/β-catenin signaling.
    Zhang H; Jiao Y; Shi C; Song X; Chang Y; Ren Y; Shi X
    Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):532-539. PubMed ID: 29701777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer.
    Hu L; Hofmann J; Zaloudek C; Ferrara N; Hamilton T; Jaffe RB
    Am J Pathol; 2002 Nov; 161(5):1917-24. PubMed ID: 12414537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.